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MHC-restricted  CTL are believed to play an  important  role in  the immune 
response to tumors and virus infections (1, 2).  CTL recognize self class I  MHC 
molecules in conjunction with foreign antigens,  which are either endogenously 
synthesized by target cells, or less commonly, exogenously provided in a suitable 
form (1, 3-6). Recent results (7-10) obtained using eukaryotic expression vectors 
containing  cloned  genes of influenza  virus  (an  orthomyxovirus)  indicate  that, 
contrary to initial  expectations,  internal  viral proteins,  which are expressed on 
infected cell surfaces in relatively low amounts, and not the abundantly expressed 
integral membrane glycoproteins serve as the major target structures recognized 
by antiinfluenza  CTL. 
To determine whether this finding is unique to orthomyxovirus-specific CTL 
or represents  a  general  feature  of CTL  recognition,  we have examined  CTL 
recognition of internal and external proteins of vesicular stomatitis virus (VSV) ~ 
(a  rhabdovirus).  VSV  is  similar  to  influenza  virus  in  that  both  are  negative- 
stranded RNA viruses that obtain their envelope by budding from the host ceil. 
The viruses differ however in many respects, including (a) the surface through 
which viral budding occurs in polarized epithelial cell lines (VSV and influenza 
virus bud through basolaterai and apical surfaces, respectively); (b) the nature of 
their genomes (influenza  virus has a  segmented genome);  and  (c) their  sites of 
replication  (VSV  replication  occurs  entirely  in  the  cytoplasm,  while  a  critical 
portion of the influenza virus replication cycle occurs in the nucleus). 
Two serotypes of VSV  (Indiana  [IND]  and  New Jersey [NJ]) can  be distin- 
guished by infectivity neutralization  assays. Initial  studies of VSV-specific CTL 
identified  two general  CTL  types:  one  specific for either  VSV~No- or VSVNj- 
infected  cells  (specific),  the  other  able  to  lyse  cells  infected  with  either  virus 
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(crossreactive) (12).  It  has  generally  been  considered  that  both  of these  CTL 
populations predominantly, if not solely, recognize the VSV glycoprotein (G), an 
integral  membrane  protein  that  coats  the  virion  surface  and  is  abundantly 
expressed on virus-infected cells.  The possibility that CTL recognize the other 
viral  proteins  (nucleocapsid  [N],  matrix  [M],  nonstructural  [NS],  or  large  [L] 
proteins), which are located internally in infected cells, has received only minor 
consideration  (13,  14).  Additionally,  the  expression  of these  proteins  on  cell 
surfaces has not been examined. 
In  this  study,  we  have  examined  the  specificity  of  anti-VSV  CTL  using 
recombinant vaccinia (VAC) viruses containing copies of genes encoding VSV G 
or  N.  We  have  found  that:  (a)  anti-VSV  recognition  of G  is  almost  entirely 
serotype-specific; (b) N  can be detected on infected cell surfaces by mAb; (c) N 
serves as a  major target antigen for crossreactive anti-VSV CTL. 
Materials and Methods 
Viruses.  Stocks  of VSV  strains  IND  and  NJ  were  grown  in  BHK-21  cells.  The 
construction and characterization of recombinant vaccinia viruses containing the IND G 
(GIND-VAC) and N genes (N~ND-VAC), NJ G (GNj-VAC) and A/PR/8 nucleoprotein (NP) 
(FLU-VAC) have been described (15). Vaccinia viruses were grown as previously described 
(10). 
Cells.  P815 cells (a DBA/2 [H-2  d] mastocytoma cell line) were maintained in RPMI 
1640 medium supplemented with 10% FCS in a humidified air/CO2 atmosphere at 37 ° C. 
k  d  d  L929 (H-2) cells expressing cloned H-2L  (LM-1) and H-2D  (DM-1) MHC class I genes 
(16) (generously provided by J.  Weis and J. Seidman, Harvard Medical School, Boston, 
MA) were maintained in Iscove's modified DMEM supplemented with 10% FCS (Iscove's 
medium) in a humidified air/COs atmosphere at 37°C. 
Mice.  6-8-wk-old  BALB/c  (H-2d),  C57B1/6  (H-2b),  and  CBA/J  (H-2  k)  mice  were 
obtained from the Jackson Laboratories (Bar Harbor, ME). 
Preparation  of Target Cells.  Target cells were prepared as described previously (10). 
Briefly,  P815  cells  were  infected  with  VAC  or  VSV  at  multiplicities  of  10  and  1, 
respectively, incubated for 5-7 h at 37°C, and labeled with NaS~CrO4 for 1 h at 37°C. 
L929 cells were prepared identically after their removal from tissue culture flasks by brief 
treatment with PBS containing 0.025% trypsin. 
Preparation of Effector Cells.  Splenocyte suspensions were prepared from mice primed 
3-8  wk  earlier  by  intravenous  injection  with  107  PFU  VAC,  or  by  intraperitoneal 
inoculation with  10  v PFU VSV. ~6 ×  107 splenocytes were cocultured in 40 ml Iscove's 
medium for 6 d at 37 °C with 3 ×  107 autologous splenocytes infected with VSV or VAC 
at a multiplicity of 10. 
Microcytotoxicity Assays.  In vitro-stimulated splenocytes in  100 IA of Iscove's medium 
were added at various ratios to round-bottom, 96-well polystyrene plates containing 104 
target cells in  100 #1 Iscove's medium. After 4 h  of incubation at 37°C,  100 #1 of the 
supernatant was removed and the concentration of released 5~CrO4 determined with a 
gamma counter. Data are expressed as percent specific release defined as: [(experimental 
cpm)  -  (spontaneous  [no  splenocytes] cpm)]/[(total [detergent]  cpm)  -  (spontaneous 
cpm)]. Spontaneous release values were always <25% of total release values. 
Monoclonal Antibodies.  mAb specific for VSV antigens were produced and character- 
ized as previously described (17). The specificity of N-specific antibodies was determined 
by immunoprecipitation. 
lmmunofluorescence.  8 h after infection with VSV or VAC,  P815 cells were pelleted 
by centrifugation and suspended at a concentration of 3 ×  107 cells/ml in PBS containing 
0.04% NaN3 and  1% BSA (HAS-BSA).  25-#1 cell suspensions were then added to100 #1 
of HAS-BSA containing hybridoma ascites fluids diluted 10  -3-10  -4. After 1.5 h incubation 
at 4°C, cells were washed three times with HAS-BSA and suspended in 25 #1 HAS-BSA YEWDELL  ET  AL.  1531 
TABLE  I 
Cytofluorographic Analysis of VSV Antigens on Infected Cell Surfaces 
Cells 
Anti-G  Anti-N ~ND  Anti-N Nj 
Percent  Intensity*  Percent  Intensity  Percent 
positive*  positive  positive  Intensity 
VSVIND  78  143  25  59  --  -- 
NIND-VAC  --  --  25  24  --  -- 
GIND-VAC  82  96  .... 
VSVNj  84  141  --  --  51  66 
GN~-VAC  82  87  .... 
Binding of mAb to viable cell surfaces 8  h  after infection with VSV or recombinant VAC viruses 
was detected by indirect immunofluorescence analyzed using a  cytofluorograph. 
* Percentage of cells binding antibody above background levels obtained using uninfected cells (for 
VSV-infected cells), or FLU-VAC-infected cells (for cells infected with VAC recombinant viruses). 
* Average relative fluorescent intensity. 
containing fluorescein-conjugated rabbit anti-mouse Ig (Dako Corp., Santa Barbara, CA) 
diluted 1:50. After 1.5 h at 4°C, cells were washed four times with HAS-BSA and either 
examined in a  Leitz photomicroscope equipped with standard epifluorescence optics or 
fixed for subsequent cytofluorograph analysis.  Cells were fixed by 10-min incubation at 
room temperature in 50 ttl PBS containing 3% paraformaldehyde. After addition of 100 
#1 0.15 M glycine, cells  were pelleted, washed with  HAS-BSA and stored overnight at 
4°C. Cells were then suspended in 400 ttl PBS, and the surface fluorescence of viable cells 
(before fixation) was quantitated using an Ortho cytofluorograph. Cells that were nonvi- 
able at the time of fixation were excluded from cytofluorographic analysis based on their 
light scattering properties (control experiments established that fixation did not alter the 
ability of the cytofluorograph to distinguish viable from nonviable cells). 
Results 
Expression  of Viral Antigens on Infected Cell Surfaces.  The expression of VSV 
gene products in P815 cells (a murine cell line used as a CTL target cell) infected 
with  VSV  or  vaccinia  virus  was  examined  by  flow  cytometry after  indirect 
immunofluorescence staining using anti-VSV mAb. These data are summarized 
in  Table  I.  Using  an  mAb  that  cross-reacts  between  GNj  and  G~ND, a  large 
percentage of cells infected with VSVNj or VSVrND was heavily stained. A similarly 
large percentage of cells infected with either GjND-VAC or GNj-VAC was stained, 
although  lower quantities  of G  were  detected.  The  specificity of binding  was 
shown by the failure of this antibody to bind cells infected with a  recombinant 
VAC  virus  containing  the  influenza  virus  NP  gene  (FLU-VAC),  and  by  the 
failure  of anti-influenza  virus  mAb  to  bind  cells  infected with  VSV  or  VAC 
recombinants containing VSV genes (not shown). 
mAb specific for NNJ  or  NIND were used to examine the expression of N  on 
infected  cell  surfaces.  -50%  of cells  infected  with  VSVNj  showed  significant 
binding  of the  anti-N  mAb.  25%  of cells infected with  VSVIND  or  NIND-VAC 
showed  binding  above  background  leels,  with  greater  amounts  of  N  being 
detected  on  VSViNo-infected  cells.  Antibody  binding  specificity  was  demon- 
strated as above (not shown). The expression of N  on infected cell surfaces was 
confirmed by direct examination of stained cells, where aggregates of stain were 
seen to be distributed on the surface of viable cells infected with either VSV or 
NIND-VAC (not shown). 1532  RECOGNITION  OF  VESICULAR STOMATITIS  VIRUS ANTIGENS 
TABLE  II 
Recognition of P815 Cells Expressing Isolated VSV Antigens by VSV-specific CTL 
Percent specific 5~Cr release 
Virus-infected  VSVIND*  VSVNj  VSVIND  VSVNj 
P815 Cells  VSVIND*  VSVNj  VSVrq  VSV~ND 
10:11  3:1  10:1  3:1  10:1  3:1  10:1  3:1 
VSVIND  67  47  47  32  63  47  54  31 
VSVNj  44  26  49  31  52  33  43  23 
GIND-VAC  37  16  13  7  12  7  12  3 
GNj-VAC  15  5  69  50  14  6  11  3 
NIND-VAC  72  35  57  27  77  49  61  23 
FLU-VAC  13  6  13  8  11  6  13  3 
Uninfected  16  5  14  7  14  6  13  5 
* Primary in vivo stimulation. 
Secondary in vitro stimulation. 
Cytotoxicity  assays  were performed using BALB/c splenocytes  at the E/T ratios indicated. 
Recognition  of Target  Cells  Expressing  Cloned  VSV Antigens  by Anti-VSV CTL. 
Splenocytes derived from BALB/c mice immunized with either VSVIN, or VSVNj 
and  stimulated in  vitro  with  autologous  splenocytes infected with  VSVIND or 
VSVNj were tested for their cytotoxic activity against uninfected P815 cells, or 
cells  infected with either  VSV  or  recombinant  VAC  viruses  (Table  II).  CTL 
capable of lysing cells infected with either  VSVNj or VSVIND were  present  in 
each of the populations tested. The MHC-restricted nature of target cell recog- 
nition was shown by the failure of these splenocytes to lyse VSV infected murine 
cells expressing  other  MHC  haplotypes (L929  [H-2k],  MC57G  [H-2b]),  which 
were lysed by histocompatible CTL (not shown). 
Cells infected with G-VAC recombinants were specifically lysed by splenocytes 
primed and stimulated with viruses containing the homologous G.  The higher 
levels of lysis of cells infected with GNj-VAC relative to lysis of GIND-VAC  was 
also observed  in other experiments,  and is probably due to differences in  the 
effector populations and  not to  levels of G  expression  on  recombinant  VAC- 
infected cells, since equivalent levels of G  were present on the targets (Table I). 
Neither target expressing cloned G  was lysed above control levels by the cross- 
reactive  CTL populations  used  in  this experiment  (either  splenocytes primed 
with one serotype and in vitro stimulated with the other serotype, or splenocytes 
primed and stimulated with a serotype containing the heterologous G), although 
low  levels  of crossreactive  lysis  of GNj-VAC  infected  cells  were  sporadically 
observed in other experiments (not shown).  The failure of cross reactive CTL 
to recognize G-VAC-infected cells was not due to interference from processes 
related to the VAC infection, since cells coinfected with GNj-VAC and VSVNj or 
G~ND-VAC and VSVIND were efficiently lysed by crossreactive CTL (not shown). 
In  contrast to the  strain-specific recognition  of G,  N~ND-VAC-infected cells 
were lysed at high levels by all four anti-VSV CTL populations, a  finding that 
was consistently repeated in a number of additional experiments. The specificity 
of CTL  recognition  of NxND-VAC-infected cells  is  indicated  by  two  findings. 
First,  BALB/c CTL  specific  for  G  (Table  III) or  influenza virus  (not  shown) 
failed to lyse these cells. Second, NiyD-VAC-infected cells were not lysed by anti- YEWDELL ET  AL.  1533 
TABLE  III 
Ability of Recombinant  VAC Viruses Containing VSV Genes to Prime for Secondary In Vitro 
VSV-specific CTL Response 
Percent specific 5ZCr release 
P815 cells  GNj-VAC*  Gsj-VAC  NXND-VAC  NIND-VAC 
VSVIsD*  VSVsj  VSVxNo  VSVNj 
14:10  4:1  14:1  4:1  14:1  4:1  50:1  4:1 
VSVIND  19  6  31  9  83  53  74  47 
VSVNj  17  5  79  44  96  62  69  44 
GNj-VAC  13  3  57  26  9  2  6  3 
GINo-VAC  13  3  23  7  4  2  3  1 
NINo-VAC  10  3  21  5  79  42  62  26 
FLU-VAC  9  2  18  3  7  1  7  1 
Uninfected  6  1  15  4  6  0  2  1 
* Primary stimulation. 
* Secondary stimulation. 
§  Cytotoxicity  assays were performed using BALB/c  splenocytes  at E/T ratios indicated. 
VSV CTL derived from MHC-incompatible mice (CBA/J [H-2 k] or C57B1/6 [H- 
2b]) (not shown). 
Priming  of Anti-VSV  CTL  by  VAC  Recombinant  Viruses.  We  have previously 
shown (8,  10,  18) that inoculation of mice with recombinant VAC viruses primes 
their splenocytes for a secondary in vitro response. Inoculation of BALB/c mice 
with  G~No-VAC only primed  splenocytes for  a  weak  response  upon  in  vitro 
challenge with VSVxNo-infected  ceils in two of four experiments, and failed in 
all four experiments to prime for a response to VSVNj (not shown). In the same 
experiments, inoculation with GNj-VAC consistently primed for a vigorous sec- 
ondary response  upon stimulation with VSVNj, and occasionally primed for a 
weak secondary response upon stimulation with VSVINo. Data from one repre- 
sentative  experiment  are  shown  in  Table  III.  VSVnj-stimulated  splenocytes 
derived from GNj-VAC mice efficiently lysed VSVNj or Gnj-VAC-infected cells. 
These cells showed weak cytotoxic activity against VSVinD-infected cells,  and 
failed to lyse G~nD-VAC-infected cells above control values. VSVIND stimulation 
of the  same  splenocytes generated  low  levels of crossreactive anti-VSV  CTL 
activity. Taken together with the low levels of lysis of G-VAC-infected cells by 
crossreactive anti-VSV CTL described above, these data indicate that recognition 
of G  by BALB/c splenocytes stimulated in  vitro secondarily is almost entirely 
serotype specific. 
Inoculation of mice with N~yD-VAC-primed splenocytes for a  vigorous CTL 
response upon stimulation with either VSVNj of VSV~ND. Both of these popula- 
tions  lysed  VSVNj- and  VSV~su-infected  cells  with  equal  efficiency, and  as 
expected, lysed Ntyo-VAC-infected cells.  Note also that these populations did 
not lyse G~ND-VAC- or GNj-VAC-infected cells above control values. Similarly, 
CTL primed by GNj-VAC  did not iyse N~Ni)-VAC-infected cells above control 
values.  Along  with  similar  findings we  have  made  using VAC  recombinants 
containing cloned influenza virus genes (manuscript in preparation), these data 
indicate that the inoculation of mice with recombinant VAC viruses only primes 1534  RECOGNITION  OF  VESICULAR  STOMATITIS  VIRUS  ANTIGENS 
TABLE  IV 
N ls Recognized  in Conjunction with the L a Molecule 
Percent specific 5tCr release 
Transfected  VSVIND*  NIND-VAC  Virus  class I gene  VSVNj  *  VSVIND 
30:1 ~  10:1  30:1  10:1 
VSVIsD  L a  53  33  45  22 
NmD-VAC  L d  53  26  34  17 
FLU-VAC  L d  13  5  4  2 
Uninfected  L d  7  3  1  0 
VSVIND  D ~  4  0  0  0 
NIND-VAC  D d  7  3  3  0 
FLU-VAC  D O  6  2  1  0 
Uninfected  D d  7  3  3  2 
*  Primary stimulation. 
* Secondary stimulation. 
Cytotoxicity  assays were  performed  using BALB/c (H-2 d)  splenocytes 
and L929 (H-2 k) target cells at E/T ratios indicated. 
their splenocytes for a secondary in vitro response to VAC virus and the foreign 
antigen encoded by the recombinant. 
N  Is Recognized  in Association with L a by Anti-VSV CTL.  The data presented 
above clearly indicate that cells expressing N are efficiently lysed by CTL. The 
MHC-restricted nature of N-specific CTL was further examined using L929 cells 
(H-2 k) transfected with cloned D  d and  L  d genes derived from BALB/c (H-2  d) 
mice (termed DM-1  and  LM-1,  respectively [Table  IV]).  VSV-infected  LM-1 
cells were specifically lysed by both secondary CTL induced by priming and in 
vitro stimulation  with  VSV,  and by a  N-specific CTL  population  induced by 
NmD-VAC priming and VSVmD  in vitro stimulation. Additionally, NmD-VAC- 
infected cells were specifically lysed by both CTL populations. In contrast, DM- 
1 cells were not lysed by VSV-specific H-2a-restricted CTL. The failure of VSV- 
specific  CTL  to  recognize  DM-1  cells  is  consistent  with  the  conclusions  of 
Ciavarra and coworkers (19, 20) that VSV-specific CTL are solely restricted to 
L  ~ in the H-2  d hapiotype. However, our finding may also be related to low levels 
of D O  expression on DM-1  cells. Indirect immunofluorescence performed using 
anti-D  d mAb followed by flow cytometry indicated that,  although  D  O was ex- 
pressed on the surface of at least 65% of these cells, the intensity of staining was 
low relative to that normally seen using P815  cells (not shown). Additionally, 
while VAC-infected DM-1  cells were specifically recognized by H-2  d restricted 
VAC-specific CTL, levels of lysis were always lower than those observed using 
LM-1 cells (not shown). 
Discussion 
We have found that N represents a major target antigen for VSV-specific CTL 
produced by secondary in vitro stimulation. The failure of earlier investigators 
(13,  14)  to detect evidence for a  major non-G specific CTL population  using 
temperature-sensitive (ts)  VSV  mutants is  possibly  explained by  the  fact that 
primary CTL populations were used in these studies. Two findings are relevant YEWDELL ET AL.  1535 
to this possibility.  First, a  number of studies (14,  21) have found that primary 
anti-VSV CTL populations are often predominantly serotype-specific, while all 
the anti-VSV CTL populations we have used are highly crossreactive. Second, 
our present results indicate that anti-G CTL are predominantly serotype-specific. 
Thus it is possible that the CTL populations used in these ts studies were largely 
G-specific. Although further experiments are needed to determine the depend- 
ence of anti-VSV CTL specificity on the mode of stimulation, it should be noted 
that Pala and Askonas (22) have shown that the H-2 restriction of antiinfluenza 
CTL depends on the site of infection, and perhaps ultimately on the cell type 
that presents antigen to the CTL. 
Our finding that G is only poorly recognized by crossreactive anti-VSV CTL 
is consistent with the findings of Sethi and Brandis (21).  It will be necessary to 
examine CTL recognition of G at the clonal level to determine whether the low 
level  of crossreactive recognition of G  reflects a  low frequency of G-specific 
crossreactive CTL able to efficiently lyse target cells, or inefficient recognition 
of G by higher-frequency crossreactive CTL. In any event, the serotype-specific 
recognition  of G  by  CTL  is  strikingly similar  to  recognition of serotypically 
distant influenza hemagglutinin molecules by influenza virus A-specific CTL (7- 
9,  18). 
A  number of recent reports  (23-26)  have described specific lysis  of virus- 
infected cells by T  cells that recognize antigen in conjunction with MHC class II 
molecules (CTL-II). Since the P815 target cell line used in the present study is 
not known to express class  II MHC molecules, it is almost certain that we have 
assayed exclusively class I-restricted CTL. Furthermore, using L cells expressing 
cloned  class  I  genes,  we  have  unequivocally  shown  class  I-restricted  CTL 
recognition of N.  It is  important to distinguish between class  I- and class  II- 
restricted CTL, since these cells have different requirements for stimulation and 
target cell recognition. CTL-II lyse targets exposed to inactivated virus or isolated 
foreign antigens (26). In contrast, class I-restricted CTL only lyse cells expressing 
endogenously produced foreign antigens  or foreign antigens artificially fused 
into the plasma membrane (1, 3, 4). Only exceptionally can target cells be lysed 
by addition of foreign antigens without known fusion activity (5, 6). 
It has generally been assumed that CTL recognize native antigen present on 
the external surface of the plasma membrane. While this may pertain to some 
antigens (integral membrane proteins such as G), it is uncertain whether CTL 
recognize native or processed forms of internal antigens such as N. In addition 
to N, a number of other internal virally encoded proteins are now known to be 
recognized by CTL. These proteins include five influenza virus proteins (NP [9, 
10],  NS1  [manuscript in preparation], three polymerases [manuscript in prepa- 
ration]), SV40 T antigen (27-29), and reovirus al protein (5). Where it has been 
possible to examine antigen expression on the cell surface using mAb (N,  NP 
[30,  31],  T  [32,  33]  al  [5]),  all  have been detected on the surface of at  least 
some cells expressing these proteins. The fact that a  number of the antibodies 
used do not bind denatured forms of the antigen supports the idea that CTL 
recognize native forms of internal antigens (33, and unpublished results). On the 
other hand, it has been shown that cells expressing truncated forms of NP (31) 
or T  antigen (34, 35) are recognized by CTL, even when it was not possible to 1536  RECOGNITION  OF  VESICULAR STOMATITIS  VIRUS ANTIGENS 
detect  the  presence  of antigenically active  fragments  in  the  target  cells  (31). 
Based on these findings, Townsend et al.  (31) proposed  that internal antigens 
are presented as suitable CTL target structures only after being processed by a 
cytoplasmic degradative pathway. Alternatively, Sharma et al. (36) have hypoth- 
esized that export of nuclear proteins to the cell surface such as T  antigen and 
influenza virus NP occurs by virtue of their interaction with the inner wall of 
the nuclear membrane. While this could pertain to T  antigen, which is present 
in cells over the course of many cell divisions, it does not explain the cell surface 
expression and CTL recognition of influenza virus NP,  which can occur on a 
high percentage of cells as rapidly as 2-4 h after infection (30). Furthermore, as 
VSV N appears to be located exclusively in the cytoplasm (37), nuclear residence 
does not seem to be an absolute requirement for either the expression of internal 
nucleic acid binding proteins on the cell surface, or their recognition by CTL. 
Summary 
It has generally been assumed that most if not all CTL specific for vesicular 
stomatitis  virus  (VSV)-infected  cells  recognize  the  viral  glycoprotein  (G),  an 
integral membrane protein abundantly expressed on infected cell surfaces. Using 
recombinant vaccinia viruses containing copies of cloned VSV genes to examine 
CTL  recognition  of VSV,  we  have  confirmed  that  G  is  recognized  by  VSV- 
specific CTL. More interestingly, however, we have also found that nucleocapsid 
protein (N), an internal virion protein, can be detected on infected cell surfaces 
using  mAb,  and  serves  as  a  major  target  antigen  for  VSV-specific  CTL.  In 
contrast to the highly serotype-specific recognition of G,  N  is recognized by a 
major population of CTL able to lyse cells infected with either the Indiana or 
New Jersey VSV serotypes. Using target cells expressing a  cloned MHC class I 
gene, we could directly show that CTL recognition of N  occurs in the context 
of the MHC L d molecule. 
Received for publication 13 February 1986. 
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